# CP101 for the Treatment of Ulcerative Colitis

> **NCT05852574** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** CP-101
- **DRUG:** CP-101 + Placebo

## Key facts

- **NCT ID:** NCT05852574
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2024-11-21
- **Final completion:** 2025-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05852574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05852574, "CP101 for the Treatment of Ulcerative Colitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05852574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*